Sign in
4

Changes in Ownership

ANI PHARMACEUTICALS INC Filed Acc 0001104659-23-078742

SVP - CORP. DEV. & STRATEGY sold 20,000 shares at $53.43 ($1,068,600)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Gassert Chad · SVP - CORP. DEV. & STRATEGY

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-07-03 Sale : show line 1 in the form 10b5-1 −20,000 $53.43 $1,068,600 353,226 I
Open-market sales · 20,000 sh · avg $53.43 · $1,068,600
Loading xslF345X04/tm2320740-1_4seq1.xml…